Frequency of 985A-to-G mutation in medium-chain acyl-CoA dehydrogenase gene among patients with sudden infant death syndrome, Reye syndrome, severe motor and intellectual disabilities and healthy newborns in Japan

Pediatrics International

Volumn 38, Issue 4, 1996, Pages 304-307

  Nagao, Masayoshi ^a  

^a National Otaru Hospital   (Japan)

Author keywords

Fatty acid oxidation disorders; Medium chain acyl CoA dehydrogenase; Reye syndrome; Severe motor and intellectual disabilities; Sudden infant death syndrome

Indexed keywords

ACYL COENZYME A DEHYDROGENASE;

ARTICLE; CHILD; GENE FREQUENCY; GENETICS; HETEROZYGOTE; HUMAN; INBORN ERROR OF METABOLISM; INFANT; MENTAL DEFICIENCY; MOTOR DYSFUNCTION; MUTATION; NEWBORN; PRESCHOOL CHILD; REYE SYNDROME; SUDDEN INFANT DEATH SYNDROME; CAUCASIAN; CLINICAL ARTICLE; DISEASE ASSOCIATION; FATTY ACID OXIDATION; GENE MUTATION; INTELLECTUAL IMPAIRMENT; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; RACE DIFFERENCE;

ACYL-COA DEHYDROGENASES; CHILD; CHILD, PRESCHOOL; GENE FREQUENCY; HETEROZYGOTE; HUMANS; INFANT; INFANT, NEWBORN; MENTAL RETARDATION; METABOLISM, INBORN ERRORS; MOVEMENT DISORDERS; MUTATION; REYE SYNDROME; SUDDEN INFANT DEATH;

EID: 0029662345     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.1996.tb03495.x     Document Type: Article

References (19)

1. Roe CR, Coates PM. Acyl-CoA dehydrogenase deficiencies. In: Scriver CR, Beudet AL, Sly WS, Valle D. (eds) The Metabolic Basis of Inherited Disease. 6th edn. McGraw Hill, New York. 1989; 889–914.
2. Editorial. Sudden infant death and inherited disorders of fat oxidation. Lancet 1986; ii: 1073–5.
3. Stanley CA, Hale DE, Coates PM et al. Medium-chain acyl-CoA dehydrogenase deficiency in children with non-ketotic hypoglycemia and low carnitine levels. Pediatr. Res. 1983; 17: 877–84.
4. Lafolla AK, Thompson RJ, Roe CR. Medium-chain acyl-CoA dehydrogenase deficiency: Clinical course in 120 affected children. J. Pediatr. 1994; 124: 409–15.
5. Rinaldo PR, O'Shea JJ, Coates PM, Hale DE, Stanley CA, Tanaka K. Medium-chain acyl-CoA dehydrogenase deficiency. Diagnosis by stable-isotope dilution measurement of urinary n-hexanoylglycine and 3-phenylpropionylglycine. N. Engl. J. Med. 1988; 319: 1308–13.
6. Kelly DP, Whelan AJ, Ogden ML et al. Molecular characterization of inherited medium-chain acyl-CoA dehydrogenase deficiency. Proc. Natl Acad. Sci. USA 1990; 87: 9236–40.
7. Matsubara Y., Narisawa K., Miyabayashi S. et al. Identification of a common mutation in patients with medium-chain acyl-CoA dehydrogenase deficiency. Biochem. Biophys. Res. Comm. 1990; 171: 498–505.
8. 985A-to-G transition, and identification of five infrequent mutations in the medium-chain acyl-CoA dehydrogenase (MCAD) gene in 55 patients with MCAD deficiency. Am. J. Hum. Genet. 1991; 49: 1280–91.
9. Gregersen N., Blakemore AIF, Winter V. et al. Specific diagnosis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in dried blood spots by a polymerase chain reaction (PCR) assay detecting a point-mutation (G985) in the MCAD gene. Clin. Chim. Acta. 1991; 203: 23–34.
10. Matsubara Y., Narisawa K., Tada K. et al. Prevalence of K329E mutation in medium-chain acyl-CoA dehydrogenase gene determined from Guthrie cards. Lancet 1991; 338: 552–3.
11. Nagao M., Raymond D., Kim J., Tanaka K. Improved PCR/Nco-I method for the molecular diagnosis of medium chain acyl-CoA dehydrogenase deficiency using dried blood samples: Two-stage amplification using two different sets of primers improves accuracy and sensitivity. Clin. Chim. Acta. 1993; 220: 165–74.
12. Blakemore AIF, Singleton H., Pollitt R. et al. The frequency of G985 MCAD mutation in the general population. Lancet 1991; 337: 298–9.
13. Gregersen N., Winter V., Curtis D. et al. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: The prevalent mutation G985 (K304E) is subject to a strong founder effect from northwestern Europe. Hum. Hered. 1993; 43: 342–50.
14. McGarry JD, Foster DW. An improved and simplified radioisotopic assay for the determination of free and esterified carnitine. J. Lipid Res. 1976; 17: 277–81.
15. Opdal SH, Vege A., Saugstad OD, Rognum TO. Is the medium-chain acyl-CoA dehydrogenase G985 mutation involved in sudden infant death in Norway? Eur. J. Pediatr. 1995; 154: 166–7.
16. Santer R., Gregersen N., Tanaka K., Hinck-Kneip C., Krawinkel M., Schaub J. The prevalence of the G985 allele of medium-chain acyl-CoA dehydrogenase deficiency among sudden infant death victims and healthy newborns in northern Germany. Eur. J. Pediatr. 1995; 154: 497.
17. Gregersen N., Winter V., Jensen PKA et al. Prenatal diagnosis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in a family with a previous fatal case of sudden unexpected death in childhood. Prenat. Diagn. 1995; 15: 82–6.
18. Nobukuni Y., Yokoo T., Ohtani Y. et al. Neonatal onset of medium-chain acyl-CoA dehydrogenase deficiency in two siblings. Brain Dev. 1988; 10: 129–134.
19. Gregersen N., Winter V., Kolvraa S. et al. Molecular analysis of medium-chain acyl-CoA dehydrogenase deficiency: A diagnostic approach. In: Coates PM, Tanaka K. (eds). New Development in Fatty Acid Oxidation. Wiley-Liss, New York. 1992; 441–52.